By Si-Yang Liu, MD, and Yi-Long Wu, MD Posted: November 12, 2019 Dr. Si-Yang Liu Dr. Yi-Long Wu In the twentieth century, adjuvant chemotherapy became the standard of care for […] Read more
Posted: November 12, 2019 Dr. Matthew Steliga, chair of the IASLC Tobacco Control and Smoking Cessation Committee and thoracic surgeon and head of the Tobacco Cessation Program at Winthrop P. […] Read more
By Marianne Davies, DNP, RN, ACNP Posted: May 27, 2019 The International Thoracic Oncology Nursing Forum (ITONF) is an independent organization to support nurses who work in lung cancer and mesothelioma […] Read more
Posted: May 27, 2019 Scott Antonia, MD, PhD, was appointed director of the newly formed DCI Center for Cancer Immunotherapy at Duke Cancer Institute. In addition to his leadership role, Dr. […] Read more
By Mirjana Rajer, MD, PhD Posted: April 1, 2019 For many years, the treatment of patients with stage III lung cancer has been a topic of intense debate among surgeons, radiation […] Read more
By Russell Bahar, Bsc and Elliot Wakeam, MD, MPH Posted: April 1, 2019 IN REFERENCE TO: Serna-Gallegos DR, et al Effects of time from completed clinical staging to surgery: Does it […] Read more
By John Armstrong, MD, FRCPI, DABR, FFRRCSI Posted: December 2018 RTOG 0214, a phase III randomized trial, is the biggest trial to date testing prophylactic cranial irradiation (PCI) in locally […] Read more
Posted: December 2018 Richard Pazdur, MD, is director of the U.S. Food and Drug Administration’s (FDA’s) Oncology Center of Excellence. Below, he discusses the current status of and future directions […] Read more
By C.A.I.R.O Journal Club Executive Board Posted: December 2018 Egypt faced major turmoil in 2011, with subsequent dramatic political changes and a rapidly developing economic crises that, within a few […] Read more
By Edgardo S. Santos Castillero, MD, FACP Posted: December 2018 Five abstracts were presented at the Presidential Symposium of the 2018 IASLC Latin America Conference on Lung Cancer, held in […] Read more